Series A · AI & Machine Learning · Copenhagen, Denmark · Founded 2021 · 4–10 employees
Invert Bio develops AI-powered bioprocess software that transforms fragmented bioprocessing data into real-time insights and automated decisions for biopharma, synthetic biology, and CDMO companies. The company's platform provides full process traceability from lab to production, with advanced data management, analytics, and machine learning modeling capabilities. Invert recently raised $20.1M in Series A funding in June 2024 and launched Invert Assist, an AI-powered analysis interface built specifically for bioprocessing. The startup was founded by experienced team members with backgrounds at Airbnb and Zeronorth, and is backed by Y Combinator, demonstrating strong technical expertise and investor confidence in their mission to accelerate bioprocess development and scale-up.